These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19875875)

  • 1. Near-infrared emitting fluorescent nanocrystals-labeled natural killer cells as a platform technology for the optical imaging of immunotherapeutic cells-based cancer therapy.
    Lim YT; Cho MY; Noh YW; Chung JW; Chung BH
    Nanotechnology; 2009 Nov; 20(47):475102. PubMed ID: 19875875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical imaging of cellular immunotherapy against prostate cancer.
    Tavri S; Jha P; Meier R; Henning TD; Müller T; Hostetter D; Knopp C; Johansson M; Reinhart V; Boddington S; Sista A; Wels WS; Daldrup-Link HE
    Mol Imaging; 2009; 8(1):15-26. PubMed ID: 19344572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfluorodecalin/[InGaP/ZnS quantum dots] nanoemulsions as 19F MR/optical imaging nanoprobes for the labeling of phagocytic and nonphagocytic immune cells.
    Lim YT; Cho MY; Kang JH; Noh YW; Cho JH; Hong KS; Chung JW; Chung BH
    Biomaterials; 2010 Jun; 31(18):4964-71. PubMed ID: 20346494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive imaging of dendritic cell migration into lymph nodes using near-infrared fluorescent semiconductor nanocrystals.
    Noh YW; Lim YT; Chung BH
    FASEB J; 2008 Nov; 22(11):3908-18. PubMed ID: 18682573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visualization of effective tumor targeting by CD8+ natural killer T cells redirected with bispecific antibody F(ab')(2)HER2xCD3.
    Scheffold C; Kornacker M; Scheffold YC; Contag CH; Negrin RS
    Cancer Res; 2002 Oct; 62(20):5785-91. PubMed ID: 12384539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real time in vivo non-invasive optical imaging using near-infrared fluorescent quantum dots.
    Morgan NY; English S; Chen W; Chernomordik V; Russo A; Smith PD; Gandjbakhche A
    Acad Radiol; 2005 Mar; 12(3):313-23. PubMed ID: 15766692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor activity of ex vivo expanded cytokine-induced killer cells against human hepatocellular carcinoma.
    Kim HM; Lim J; Yoon YD; Ahn JM; Kang JS; Lee K; Park SK; Jeong YJ; Kim JM; Han G; Yang KH; Kim YJ; Kim Y; Han SB
    Int Immunopharmacol; 2007 Dec; 7(13):1793-801. PubMed ID: 17996690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of cytokine-induced killer cells against human lung cancer.
    Kim HM; Lim J; Park SK; Kang JS; Lee K; Lee CW; Lee KH; Yun MJ; Yang KH; Han G; Kwon SW; Kim Y; Han SB
    Int Immunopharmacol; 2007 Dec; 7(13):1802-7. PubMed ID: 17996691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of human natural killer and lymphokine-activated killer cell cytotoxicity against Toxoplasma gondii trophozoites and brain cysts.
    Dannemann BR; Morris VA; Araujo FG; Remington JS
    J Immunol; 1989 Oct; 143(8):2684-91. PubMed ID: 2477453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell-based immunotherapy in cancer: current insights and future prospects.
    Sutlu T; Alici E
    J Intern Med; 2009 Aug; 266(2):154-81. PubMed ID: 19614820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study.
    Chan JK; Hamilton CA; Cheung MK; Karimi M; Baker J; Gall JM; Schulz S; Thorne SH; Teng NN; Contag CH; Lum LG; Negrin RS
    Clin Cancer Res; 2006 Mar; 12(6):1859-67. PubMed ID: 16551871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel approaches using natural killer cells in cancer therapy.
    Suck G
    Semin Cancer Biol; 2006 Oct; 16(5):412-8. PubMed ID: 16914327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of stem cell factor gene-modified human natural killer cell line, NK-92 cells: implication in NK cell-based adoptive cellular immunotherapy.
    Zhang J; Sun R; Wei H; Zhang J; Tian Z
    Oncol Rep; 2004 May; 11(5):1097-106. PubMed ID: 15069553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of IL-4 in proliferation and differentiation of human natural killer cells. Study of an IL-4-dependent versus an IL-2-dependent natural killer cell clone.
    Hayakawa K; Salmeron MA; Kornbluth J; Bucana C; Itoh K
    J Immunol; 1991 Apr; 146(7):2453-60. PubMed ID: 1900882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biology of human natural killer cells.
    Whiteside TL; Herberman RB
    Ann Ist Super Sanita; 1990; 26(3-4):335-48. PubMed ID: 2091502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
    Lin SJ; Kuo ML
    Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
    Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
    Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering.
    Ayello J; van de Ven C; Fortino W; Wade-Harris C; Satwani P; Baxi L; Simpson LL; Sanger W; Pickering D; Kurtzberg J; Cairo MS
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):608-22. PubMed ID: 16737934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.
    Rabinowich H; Vitolo D; Altarac S; Herberman RB; Whiteside TL
    J Immunol; 1992 Jul; 149(1):340-9. PubMed ID: 1535088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.